ArticleFrontiers in oncology2022

Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1).

Dongcheng Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.